TL;DR
Get coffee and tea gear delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
Food Safety News reports that 50 people were sickened in a multistate E. coli O157:H7 outbreak under joint FDA-USDA investigation. The publisher says a lawsuit identified the product as Trader Joe’s Tarragon Chicken Salad Wraps and alleges they were made by F&S Fresh Foods; federal agencies have not publicly named the supplier. The author says two proposed FDA petitions would change disclosure rules, but the petitions have not yet been filed.
Fifty people have been sickened in a multistate E. coli O157:H7 outbreak that federal agencies are investigating, while the public investigation entry identifies only a suspect multi-ingredient chicken wrap, according to a Food Safety News commentary. The publisher says a lawsuit filed October 15 identified the product as Trader Joe’s Tarragon Chicken Salad Wraps and that, based on information learned in the case, they were made by F&S Fresh Foods; FDA and USDA’s Food Safety and Inspection Service have not publicly named that supplier in the material provided.
The investigation is listed as reference #1421 by FDA and USDA 2026-04 by FSIS. The Food Safety News account says the agencies are investigating together and that its public entry reads, “Multi-ingredient wrap with chicken (suspect).” The source says the agencies have not publicly provided a brand, retailer, manufacturer, affected states, hospitalization count, ingredient, recall notice or public health alert in that entry. These are claims made in the publisher’s account, not independently documented agency statements included in the supplied material.
The publisher says the product was identified publicly through Gottlieb v. Trader Joe’s Co., a federal lawsuit filed on October 15, rather than through an agency announcement. The author identifies F&S Fresh Foods of Vineland, New Jersey, as the company that made the wraps for Trader Joe’s, based on information learned in the case. The commentary also says F&S quality staff contacted one of the author’s clients. The source does not provide the lawsuit itself, agency records or a response from Trader Joe’s or F&S, so those details remain attributed to the author.
The source says the wraps were “proactively removed from the market” and are past their shelf life. It argues that because the action was not called a recall, it did not trigger a recall classification or a published store list. It also says the agencies have not clarified whether the ingredient under investigation went into other products made by F&S for other retailers. The supplied text does not establish which ingredient is suspected or whether products beyond the wraps are implicated.
Why Supplier Disclosure Matters
Identifying a supplier can help consumers understand which products may be connected to an outbreak and help retailers and public health officials assess whether other products share an ingredient or production source. The author’s concern is that a product being removed from shelves without a formal recall could leave consumers with less information about where it was sold and who made it.
That concern is particularly relevant here because the publisher says the wraps are no longer within their shelf-life period, but the investigation is still associated with 50 reported illnesses. The source does not say whether any implicated food remains in homes or commerce, nor does it give the outbreak’s state-by-state distribution or severity beyond the illness count. Without those details, readers cannot use the account to determine individual exposure or current risk.
The proposed policy debate is broader than this product: should a company’s identity and distribution information be disclosed when evidence links it to an outbreak, even if the product has been withdrawn without being classified as a recall? Clear, consistently applied disclosure rules could make agency decisions easier to scrutinize. Naming a firm also carries reputational consequences, which is why any process would need to distinguish a documented investigative link from a final finding of responsibility.
digital food thermometer instant read
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Earlier Outbreak Disclosures
The Food Safety News commentary argues that federal agencies have named companies in previous investigations after products were gone or past shelf life. It cites examples including the 2006 Dole spinach outbreak; several 2018 romaine investigations; and 2021 and 2022 outbreaks involving named salad or strawberry businesses. Those examples are presented by the author to challenge the idea that product age alone prevents disclosure. The supplied material does not include the underlying agency notices, so the examples and their descriptions should be understood as the source’s account.
The author also points to a 2013 E. coli outbreak involving chicken salads made by Glass Onion Catering and sold at Trader Joe’s. The commentary says CDC named both companies and FSIS listed the products in a recall. It compares that case with the current investigation because both involved E. coli O157:H7, chicken salad products and the same retailer. The source says the earlier outbreak sickened 33 people; it does not provide a direct agency comparison explaining why disclosure differs now.
More recent examples in the commentary include a May 2026 FSIS public health alert naming The Kebab Shop restaurants and a beef-kofta producer, and two romaine investigations in which the publisher says FDA did not initially name firms. The author argues that the difference between disclosure and silence appears tied to whether a recall was issued. That is the author’s interpretation; the supplied material does not include a formal FDA explanation of the current agency decision.
“Multi-ingredient wrap with chicken (suspect).”
— Food Safety News publisher, describing the public investigation entry
food safety refrigerator thermometer
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What the Investigation Has Not Said
The supplied material does not include an FDA or FSIS response confirming the suspected product, naming F&S Fresh Foods, or explaining why the companies have not been identified publicly. It also does not include the lawsuit, laboratory or traceback records, or a statement from Trader Joe’s or F&S. Accordingly, the manufacturer identification and account of the investigation’s evidence remain attributed to the Food Safety News publisher.
Key public-health details are absent from the source: the states where people became ill, illness onset dates, hospitalization count, whether anyone died, the implicated ingredient, product distribution, and whether any related products remain available. The text says 50 people were sickened, but does not give a reporting cutoff or explain whether the count may change. It is also not clear whether investigators have reached a final conclusion about the source of the illnesses.
The publisher says two companion citizen petitions have been prepared but are not yet filed. The supplied text describes the first petition’s goals but ends before giving the full proposal or details of the second petition. No agency action on either proposal is reported.
food storage containers airtight BPA free
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Petitions Await Review Before Filing
The author says the two proposed citizen petitions are being shared for review before submission to FDA. The first, called Outbreak Firm Disclosure, would ask FDA to use notice-and-comment rulemaking to define when a firm’s identity and distribution information can be disclosed in an outbreak investigation. As described in the source, it would apply when epidemiology implicates a food and traceback or laboratory evidence, including whole genome sequencing, points to a firm.
The proposed rule would cover food removed from commerce whether the action is called a recall, market withdrawal, stock recovery or “proactive removal,” including products past shelf life. The author says the petition would place the burden on a firm seeking secrecy to demonstrate a genuine trade secret in writing and on the record, allow one business day for correction of factual errors, and require a prominent correction if a named firm is later cleared. These are proposals, not current FDA requirements.
The source says a second companion petition has also been prepared, but the supplied material does not describe its contents. The immediate next steps are therefore for the author to complete public review and file the petitions, and for FDA and FSIS to provide any further public information about the outbreak. The timing of either development is not given.
As an affiliate, we earn on qualifying purchases.
Key Questions
How many people have been sickened?
The Food Safety News source reports 50 people sickened in a multistate E. coli O157:H7 outbreak. It does not provide a reporting cutoff or say whether the count has changed since publication.
What product is suspected?
The public investigation entry quoted in the source says “Multi-ingredient wrap with chicken (suspect).” The publisher identifies the product as Trader Joe’s Tarragon Chicken Salad Wraps, based on a federal lawsuit filed October 15. The supplied material does not include an agency confirmation of that identification.
Who does the publisher say made the wraps?
The publisher says the wraps were made for Trader Joe’s by F&S Fresh Foods of Vineland, New Jersey, based on information learned in the lawsuit. The source says federal agencies have not publicly named F&S in connection with the investigation.
Have the proposed FDA petitions been filed?
No. The author says the two companion petitions have been prepared but are not yet filed because the author wants more people to review them first. The supplied material describes the first petition but not the second.
Is the outbreak investigation complete?
The supplied source describes the investigation as ongoing and provides no final agency conclusion. It does not identify the implicated ingredient, affected states, hospitalization count, or whether other products may be involved.
Source: rss
Evergreen bestsellers Picks
bestsellers
As an affiliate, we earn on qualifying purchases.
